1200 Pharma LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.1200pharma.com
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
- First Posted Date
- 2021-11-02
- Last Posted Date
- 2024-03-12
- Lead Sponsor
- 1200 Pharma, LLC
- Target Recruit Count
- 68
- Registration Number
- NCT05103046
- Locations
- 🇺🇸
Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Winship Institute of Emory University, Atlanta, Georgia, United States
🇺🇸UCLA - JCCC Clinical Research Unit, Los Angeles, California, United States
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Phase 1
Terminated
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- 1200 Pharma, LLC
- Target Recruit Count
- 32
- Registration Number
- NCT04761601
- Locations
- 🇺🇸
Torrance Memorial, Torrance, California, United States
🇺🇸Mary Crowley Cancer Research, Dallas, Texas, United States
🇺🇸Winship Institute of Emory University, Atlanta, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath